Physician profile
Heidi J Combs
NPI 1184605081
$322.41
in general payments reported to CMS, 2019-2025
11 companies · $18.55 in 2025
The $18.55 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $165 · 2022: $85.23 · 2023: $53.67 · 2025: $18.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $72.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $72.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $89.32 | 2021-2022 | |
| Abbvie INC. | $62.15 | 2021-2025 | |
| Kci USA, INC. | $29.52 | 2022 | |
| Myriad Genetic Laboratories, INC. | $26.88 | 2021 | |
| Boston Scientific Corporation | $18.59 | 2023 | Watchman Access System |
| Exact Sciences Corporation | $18.46 | 2023 | Cologuard Collection Kit |
| Kerecis Limited | $16.62 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Medtronic, INC. | $16.27 | 2022 | |
| Smith+Nephew, INC. | $15.27 | 2021 | |
| Braintree Laboratories, INC. | $15.18 | 2021 | |
| Paratek Pharmaceuticals, INC. | $14.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidi Combs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.